Brief: Candel Therapeutics Inc Names Jason Amello As Chief Financial Officer
07/09/2022 13:08
Sept 7 (Reuters) - Candel Therapeutics Inc CADL.O :
* CANDEL THERAPEUTICS INC - JASON A. AMELLO JOINS CANDEL AS
CHIEF
FINANCIAL OFFICER
* CANDEL THERAPEUTICS INC - AMELLO IS JOINING CANDEL
EFFECTIVE
SEPTEMBER 21, 2022, AND IS REPLACING JOHN CANEPA, CANDEL'S
CURRENT CFO
Source text for Eikon: ID:nGNX6ZcRVC
Further company coverage: CADL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)